Notice2022-04274
Center for Scientific Review; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 1, 2022
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 40 (Tuesday, March 1, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 40 (Tuesday, March 1, 2022)]
[Notices]
[Pages 11453-11454]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-04274]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Molecular Neurogenetic Labeling and Imaging Techniques.
Date: March 23, 2022.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mary G. Schueler, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5214, MSC 7846, Bethesda, MD
20892, 301-915-6301, <a href="/cdn-cgi/l/email-protection#c9a4a8bbb0aeba89aababbe7a7a0a1e7aea6bf"><span class="__cf_email__" data-cfemail="375a56454e50447754444519595e5f19505841">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Speech, Language and Communication.
Date: March 25, 2022.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sara Louise Hargrave, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3170, Bethesda, MD 20892, (301)
443-7193, <a href="/cdn-cgi/l/email-protection#1b737a697c697a6d7e68775b767a727735757273357c746d"><span class="__cf_email__" data-cfemail="5c343d2e3b2e3d2a392f301c313d353072323534723b332a">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Infectious Diseases and Immunology.
Date: April 4-5, 2022.
Time: 9:00 a.m. to 6:00 p.m.
[[Page 11454]]
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Andrew M. Wolfe, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214, Bethesda, MD 20892, 301-
402-3019, <a href="/cdn-cgi/l/email-protection#ddbcb3b9afb8aaf3aab2b1bbb89db3b4b5f3bab2ab"><span class="__cf_email__" data-cfemail="5b3a353f293e2c752c34373d3e1b353233753c342d">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Eukaryotic Pathogen Drug Discovery and Resistance.
Date: April 5, 2022.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Marcus Ferrone, PHARMD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-402-2371,
<a href="/cdn-cgi/l/email-protection#b4d9d5c6d7c1c79ad2d1c6c6dbdad1f4dadddc9ad3dbc2"><span class="__cf_email__" data-cfemail="b7dad6c5d4c2c499d1d2c5c5d8d9d2f7d9dedf99d0d8c1">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: February 24, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-04274 Filed 2-28-22; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on March 1, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.